具有抗菌性能的纳米铜生物材料的设计与合成

IF 3.8 Q2 BIOCHEMISTRY & MOLECULAR BIOLOGY ACS Bio & Med Chem Au Pub Date : 2023-04-11 DOI:10.1021/acsbiomedchemau.2c00089
Clara Ortega-Nieto, Noelia Losada-Garcia, Benevides C. Pessela, Pilar Domingo-Calap and Jose M. Palomo*, 
{"title":"具有抗菌性能的纳米铜生物材料的设计与合成","authors":"Clara Ortega-Nieto,&nbsp;Noelia Losada-Garcia,&nbsp;Benevides C. Pessela,&nbsp;Pilar Domingo-Calap and Jose M. Palomo*,&nbsp;","doi":"10.1021/acsbiomedchemau.2c00089","DOIUrl":null,"url":null,"abstract":"<p >In this work, nanostructured copper materials have been designed, synthetized, and evaluated in order to produce a more efficient and sustainable copper bionanohybrid with catalytical and antimicrobial properties. Thus, conditions are sought where the most critical steps are reduced or minimized, such as the use of reducing agents or the cryogenization step. In addition, the new materials have been characterized through different techniques, and their oxidative and reductive capacities, as well as their antimicrobial activity, have been evaluated. The addition of different quantities of a reducing agent in the synthesis method generated copper bionanohybrids with different metallic species, nanoparticles sizes, and structures. The antimicrobial properties of the bionanohybrids were studied against different strains of Gram-positive and Gram-negative bacteria through two different methods: by counting the CFU and via the disk diffusion test, respectively. The bionanohybrids have demonstrated that different efficiencies depending on the bacterial strain were confronted with. The <b>Cu-PHOS-100% R</b> hybrids with the highest percentage of reduction showed the best antimicrobial efficiency against <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i> bacteria (&gt;96 or &gt;77% in 4 h, respectively) compared to 31% bacteria reduction using <b>Cu-PHOS-0% R</b>. Also, the antimicrobial activity against <i>Bacillus subtilis</i> materials was obtained with <b>Cu-PHOS-100% R</b> (31 mm inhibition zone and 125 μg/mL minimum inhibitory concentration value). Interestingly, the better antimicrobial activity of the nanobiohybrids against Gram-positive bacteria <i>Mycobacterium smegmatis</i> was obtained with some with a lower reduction step in the synthesis, <b>Cu-PHOS-10% R</b> or <b>Cu-PHOS-20% R</b> (&gt;94% bacterial reduction in 4 h).</p>","PeriodicalId":29802,"journal":{"name":"ACS Bio & Med Chem Au","volume":"3 4","pages":"349–358"},"PeriodicalIF":3.8000,"publicationDate":"2023-04-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://pubs.acs.org/doi/epdf/10.1021/acsbiomedchemau.2c00089","citationCount":"1","resultStr":"{\"title\":\"Design and Synthesis of Copper Nanobiomaterials with Antimicrobial Properties\",\"authors\":\"Clara Ortega-Nieto,&nbsp;Noelia Losada-Garcia,&nbsp;Benevides C. Pessela,&nbsp;Pilar Domingo-Calap and Jose M. Palomo*,&nbsp;\",\"doi\":\"10.1021/acsbiomedchemau.2c00089\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p >In this work, nanostructured copper materials have been designed, synthetized, and evaluated in order to produce a more efficient and sustainable copper bionanohybrid with catalytical and antimicrobial properties. Thus, conditions are sought where the most critical steps are reduced or minimized, such as the use of reducing agents or the cryogenization step. In addition, the new materials have been characterized through different techniques, and their oxidative and reductive capacities, as well as their antimicrobial activity, have been evaluated. The addition of different quantities of a reducing agent in the synthesis method generated copper bionanohybrids with different metallic species, nanoparticles sizes, and structures. The antimicrobial properties of the bionanohybrids were studied against different strains of Gram-positive and Gram-negative bacteria through two different methods: by counting the CFU and via the disk diffusion test, respectively. The bionanohybrids have demonstrated that different efficiencies depending on the bacterial strain were confronted with. The <b>Cu-PHOS-100% R</b> hybrids with the highest percentage of reduction showed the best antimicrobial efficiency against <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i> bacteria (&gt;96 or &gt;77% in 4 h, respectively) compared to 31% bacteria reduction using <b>Cu-PHOS-0% R</b>. Also, the antimicrobial activity against <i>Bacillus subtilis</i> materials was obtained with <b>Cu-PHOS-100% R</b> (31 mm inhibition zone and 125 μg/mL minimum inhibitory concentration value). Interestingly, the better antimicrobial activity of the nanobiohybrids against Gram-positive bacteria <i>Mycobacterium smegmatis</i> was obtained with some with a lower reduction step in the synthesis, <b>Cu-PHOS-10% R</b> or <b>Cu-PHOS-20% R</b> (&gt;94% bacterial reduction in 4 h).</p>\",\"PeriodicalId\":29802,\"journal\":{\"name\":\"ACS Bio & Med Chem Au\",\"volume\":\"3 4\",\"pages\":\"349–358\"},\"PeriodicalIF\":3.8000,\"publicationDate\":\"2023-04-11\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://pubs.acs.org/doi/epdf/10.1021/acsbiomedchemau.2c00089\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"ACS Bio & Med Chem Au\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://pubs.acs.org/doi/10.1021/acsbiomedchemau.2c00089\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"BIOCHEMISTRY & MOLECULAR BIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Bio & Med Chem Au","FirstCategoryId":"1085","ListUrlMain":"https://pubs.acs.org/doi/10.1021/acsbiomedchemau.2c00089","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 1

摘要

在这项工作中,已经设计、合成和评估了纳米结构铜材料,以生产具有催化和抗菌性能的更高效和可持续的铜-生物纳米杂化物。因此,寻求减少或最小化最关键步骤的条件,例如使用还原剂或冷冻步骤。此外,通过不同的技术对新材料进行了表征,并对其氧化和还原能力以及抗菌活性进行了评估。在合成方法中添加不同量的还原剂产生了具有不同金属种类、纳米颗粒尺寸和结构的铜-生物纳米杂化物。采用菌落总数计数法和纸片扩散法两种不同的方法,研究了仿生杂交体对不同革兰氏阳性菌和革兰氏阴性菌的抗菌性能。仿生杂交体已经证明,不同菌株所面临的效率不同。与使用Cu-PHOS-0%R减少31%的细菌相比,具有最高减少百分比的Cu-PHOS-10%R杂交种对大肠杆菌和肺炎克雷伯菌显示出最佳的抗菌效率(在4小时内分别>96或>77%)。此外,Cu-PHOS-100%R(31mm抑菌带和125μ。有趣的是,纳米生物杂化物对革兰氏阳性菌耻垢分枝杆菌具有更好的抗菌活性,其中一些在合成中具有较低的还原步骤,Cu-PHOS-10%R或Cu-PHOS-20%R(4小时内细菌还原>94%)。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

摘要图片

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Design and Synthesis of Copper Nanobiomaterials with Antimicrobial Properties

In this work, nanostructured copper materials have been designed, synthetized, and evaluated in order to produce a more efficient and sustainable copper bionanohybrid with catalytical and antimicrobial properties. Thus, conditions are sought where the most critical steps are reduced or minimized, such as the use of reducing agents or the cryogenization step. In addition, the new materials have been characterized through different techniques, and their oxidative and reductive capacities, as well as their antimicrobial activity, have been evaluated. The addition of different quantities of a reducing agent in the synthesis method generated copper bionanohybrids with different metallic species, nanoparticles sizes, and structures. The antimicrobial properties of the bionanohybrids were studied against different strains of Gram-positive and Gram-negative bacteria through two different methods: by counting the CFU and via the disk diffusion test, respectively. The bionanohybrids have demonstrated that different efficiencies depending on the bacterial strain were confronted with. The Cu-PHOS-100% R hybrids with the highest percentage of reduction showed the best antimicrobial efficiency against Escherichia coli and Klebsiella pneumoniae bacteria (>96 or >77% in 4 h, respectively) compared to 31% bacteria reduction using Cu-PHOS-0% R. Also, the antimicrobial activity against Bacillus subtilis materials was obtained with Cu-PHOS-100% R (31 mm inhibition zone and 125 μg/mL minimum inhibitory concentration value). Interestingly, the better antimicrobial activity of the nanobiohybrids against Gram-positive bacteria Mycobacterium smegmatis was obtained with some with a lower reduction step in the synthesis, Cu-PHOS-10% R or Cu-PHOS-20% R (>94% bacterial reduction in 4 h).

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
ACS Bio & Med Chem Au
ACS Bio & Med Chem Au 药物、生物、化学-
CiteScore
4.10
自引率
0.00%
发文量
0
期刊介绍: ACS Bio & Med Chem Au is a broad scope open access journal which publishes short letters comprehensive articles reviews and perspectives in all aspects of biological and medicinal chemistry. Studies providing fundamental insights or describing novel syntheses as well as clinical or other applications-based work are welcomed.This broad scope includes experimental and theoretical studies on the chemical physical mechanistic and/or structural basis of biological or cell function in all domains of life. It encompasses the fields of chemical biology synthetic biology disease biology cell biology agriculture and food natural products research nucleic acid biology neuroscience structural biology and biophysics.The journal publishes studies that pertain to a broad range of medicinal chemistry including compound design and optimization biological evaluation molecular mechanistic understanding of drug delivery and drug delivery systems imaging agents and pharmacology and translational science of both small and large bioactive molecules. Novel computational cheminformatics and structural studies for the identification (or structure-activity relationship analysis) of bioactive molecules ligands and their targets are also welcome. The journal will consider computational studies applying established computational methods but only in combination with novel and original experimental data (e.g. in cases where new compounds have been designed and tested).Also included in the scope of the journal are articles relating to infectious diseases research on pathogens host-pathogen interactions therapeutics diagnostics vaccines drug-delivery systems and other biomedical technology development pertaining to infectious diseases.
期刊最新文献
Issue Editorial Masthead Issue Publication Information New Catalytic Residues and Catalytic Mechanism of the RNase T1 Family New Catalytic Residues and Catalytic Mechanism of the RNase T1 Family Design, Synthesis, and Biological Evaluation of Darunavir Analogs as HIV-1 Protease Inhibitors
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1